The Eph-Receptor A7 Is a Soluble Tumor Suppressor for Follicular Lymphoma von Oricchio, Elisa, Nanjangud, Gouri, Wolfe, Andrew L., Schatz, Jonathan H., Mavrakis, Konstantinos J., Jiang, Man, Liu, Xiaoping, Bruno, Joanne, Heguy, Adriana, Olshen, Adam B., Socci, Nicholas D., Teruya-Feldstein, Julie, Weis-Garcia, Frances, Tam, Wayne, Shaknovich, Rita, Melnick, Ari, Himanen, Juha P., Chaganti, R.S.K., Wendel, Hans-Guido

Volltext

Structure of the EphB6 receptor ectodomain von Mason, Emilia O., Goldgur, Yehuda, Robev, Dorothea, Freywald, Andrew, Nikolov, Dimitar B., Himanen, Juha P.

Volltext

Architecture of Eph receptor clusters von Himanen, Juha P, Yermekbayeva, Laila, Janes, Peter W, Walker, John R, Xu, Kai, Atapattu, Lakmali, Rajashankar, Kanagalaghatta R, Mensinga, Anneloes, Lackmann, Martin, Nikolov, Dimitar B, Dhe-Paganon, Sirano

Volltext

Fully human monoclonal antibody targeting the cysteine-rich substrate-interacting region of ADAM17 on cancer cells von Saha, Nayanendu, Lee, Sang Gyu, Brockmann, Eeva-Christine, de la Cruz, M. Jason, Goldgur, Yehuda, Mendoza, Rachelle P., Stanchina, Elisa de, Love, Tanzy M., Marvald, Josh, Xu, Yan, Xu, Kai, Himanen, Juha P., Lamminmäki, Urpo, Veach, Darren, Nikolov, Dimitar B.

Volltext

Insights into Eph receptor tyrosine kinase activation from crystal structures of the EphA4 ectodomain and its complex with ephrin-A5 von Xu, Kai, Tzvetkova-Robev, Dorothea, Xu, Yan, Goldgur, Yehuda, Chan, Yee-Peng, Himanen, Juha P., Nikolov, Dimitar B.

Volltext

Integration of cancer-related genetic landscape of Eph receptors and ephrins with proteomics identifies a crosstalk between EPHB6 and EGFR von Hanover, Glinton, Vizeacoumar, Frederick S., Banerjee, Sara L., Nair, Raveena, Dahiya, Renuka, Osornio-Hernandez, Ana I., Morales, Alain Morejon, Freywald, Tanya, Himanen, Juha P., Toosi, Behzad M., Bisson, Nicolas, Vizeacoumar, Franco J., Freywald, Andrew

Volltext

Host Cell Recognition by the Henipaviruses: Crystal Structures of the Nipah G Attachment Glycoprotein and Its Complex with Ephrin-B3 von Xu, Kai, Rajashankar, Kanagalaghatta R., Chan, Yee-Peng, Himanen, Juha P., Broder, Christopher C., Nikolov, Dimitar B.

Volltext

The Ephb2 Receptor Uses Homotypic, Head-to-Tail Interactions within Its Ectodomain as an Autoinhibitory Control Mechanism von Xu, Yan, Robev, Dorothea, Saha, Nayanendu, Wang, Bingcheng, Dalva, Matthew B., Xu, Kai, Himanen, Juha P., Nikolov, Dimitar B.

Volltext

Binding of EphrinA5 to RET receptor tyrosine kinase: An in vitro study von Liu, Yixin, Kaljunen, Heidi, Pavić, Ana, Saarenpää, Tuulia, Himanen, Juha P, Nikolov, Dimitar B, Goldman, Adrian

Volltext

Tie2 and Eph receptor tyrosine kinase activation and signaling von Barton, William A, Dalton, Annamarie C, Seegar, Tom C M, Himanen, Juha P, Nikolov, Dimitar B

Volltext

ADAM proteases: Emerging role and targeting of the non-catalytic domains von Saha, Nayanendu, Robev, Dorothea, Himanen, Juha P., Nikolov, Dimitar B.

Volltext

Ectodomain structures of Eph receptors von Himanen, Juha P.

Volltext

Homotypic receptor-receptor interactions regulating Eph signaling von Nikolov, Dimitar B, Xu, Kai, Himanen, Juha P

Volltext

Eph/ephrin recognition and the role of Eph/ephrin clusters in signaling initiation von Nikolov, Dimitar B., Xu, Kai, Himanen, Juha P.

Volltext

Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19 von Mendoza, Rachelle, Saha, Nayanendu, Momeni, Amir, Gabutan, Elmer, Alawad, Mouyed, Dehghani, Amir, Diks, John, Lin, Bo, Wang, Donghai, Alshal, Mohamed, Fyke, William, Wang, Bingcheng, Himanen, Juha P., Premsrirut, Prem, Nikolov, Dimitar B.

Volltext

Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex von Nikolov, Dimitar B, Barton, William A, Tzvetkova-Robev, Dorothea, Miranda, Edward P, Kolev, Momchil V, Rajashankar, Kanagalaghatta R, Himanen, Juha P

Volltext

Therapeutic potential of targeting the Eph/ephrin signaling complex von Saha, Nayanendu, Robev, Dorothea, Mason, Emilia O., Himanen, Juha P., Nikolov, Dimitar B.

Volltext

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy von El Zawily, Amr, Vizeacoumar, Frederick S, Dahiya, Renuka, Banerjee, Sara L, Bhanumathy, Kalpana K, Elhasasna, Hussain, Hanover, Glinton, Sharpe, Jessica C, Sanchez, Malkon G, Greidanus, Paul, Stacey, R Greg, Moon, Kyung-Mee, Alexandrov, Ilya, Himanen, Juha P, Nikolov, Dimitar B, Fonge, Humphrey, White, Aaron P, Foster, Leonard J, Wang, Bingcheng, Toosi, Behzad M, Bisson, Nicolas, Mirzabekov, Tajib A, Vizeacoumar, Franco J, Freywald, Andrew

Volltext

Biological and Structural Characterization of Glycosylation on Ephrin-A1, a Preferred Ligand for EphA2 Receptor Tyrosine Kinase von Ferluga, Sara, Hantgan, Roy, Goldgur, Yehuda, Himanen, Juha P., Nikolov, Dimitar B., Debinski, Waldemar

Volltext

Crystal structure of the ligand-binding domain of the receptor tyrosine kinase EphB2 von Nikolov, Dimitar B, Himanen, Juha-Pekka, Henkemeyer, Mark

Volltext